Diagmond 2025 | WONGENY invites you to attend the In Vitro Diagnostic Innovation Development and Upstream Solution Conference

Conference Introduction

On May 28-29, 2025, the Diagman In Vitro Diagnostic Innovation Development and Upstream Solution Conference will be grandly held at the Suzhou Shishan International Convention Center. WONGENY booth number: T-02, Hall A. Welcome to visit our booth for guidance. We look forward to discussing the latest trends in the industry, sharing experiences, and negotiating business cooperation with you.

This exhibition has newly built a 100 square meter intelligent experience area, showcasing the full process of one-stop CDMO services in a panoramic manner. Covering chip and instrument research and development, mold design, precision injection molding, process optimization, and large-scale production, integrating life science instruments, biochips, and automated production lines. Through real-life demonstrations of core equipment such as molecular POCT systems, fluorescence PCR machines, ultrasonic disruptors, fully automatic cup sorting systems, and microfluidic chip production lines, the efficient conversion chain of medical devices from conceptual design, prototype validation to mass production is fully demonstrated.

WONGENY Special Forum

At the same time, WONGENY is vigorously creating the "Microfluidic Technology Forum", focusing on the dual themes of "technology platform construction industrialization landing". This time, we will use a three-dimensional perspective of cutting-edge technology analysis, scenario based solutions, and industry university research practical cases to deeply analyze the microfluidic technology platform. We sincerely invite colleagues to gather in Suzhou and explore the boundaries of flow control innovation with industry experts!

WONGENY speech topic one:

China's IVD power under global changes: From 'Made in China' to 'Global Intelligent Manufacturing', from 'Following' to 'Leading the Value Ecological Chain'

WONGENY speech topic two:

Global top microfluidic technology platformization: paradigm shift from single point breakthrough to multi domain ecosystem construction

WONGENY speech topic three:

The industrial dilemma of microfluidic chips: pseudo proposition or real bottleneck? Analyzing the Mass Production Curse of Product Commercialization

Forum time: May 28th 10:00-17:00

Forum Location: Suzhou Shishan International Convention Center - Conference Room 9

WONGENY

The company was established in Suzhou in 2018 and is the pioneer of fully automated microfluidic chip production lines worldwide. As a key state-owned capital investment enterprise in Suzhou, it has received multiple rounds of investment from state-owned capital and market-oriented funds. After years of research and development accumulation, we currently have OEM/ODM/CDMO service capabilities that integrate automation, chip consumables, and life science instruments, which can meet customers' multi-dimensional needs for research and development, manufacturing, and production. Our service areas cover in vitro diagnostics, medical devices, life sciences, biomedicine, etc. We specialize in the research and development, manufacturing, production process development, mold manufacturing, and mass production services of high-value biological consumables and life science instruments represented by microfluidic chips. We also provide customers with high-quality services in molecular testing, cell culture, immunotherapy, biopharmaceuticals, medical devices, and other areas.